Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2Other hematologic neoplasm 2Head & Neck 2Genitourinary 2Gastrointestinal 2Thoracic 1Sarcoma 1Plasma cell 1Other 1Lymphoid 1

Conditions

Thromboembolism 1Respiratory Insufficiency 1Pneumonia 1Myocardial Infarction 1Lung Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Acute Coronary Syndrome 1

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sodium Bicarbonate × Thoracic × Clear all
NCT01370278 2023-08-25

Clearance Of Mucus In Stents (COMIS)

M.D. Anderson Cancer Center

Phase NA Completed
43 enrolled
Thoracic

Angina, Unstable, Arrhythmias, Cardiac, Lung Neoplasms, Myocardial Infarction, Pneumonia, Respiratory Insufficiency, Thromboembolism, Acute Coronary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡